FibroGen (FGEN) PT Lowered to $2 at Goldman Sachs

June 27, 2023 6:03 AM EDT
Get Alerts FGEN Hot Sheet
Price: $1.82 -3.7%

Rating Summary:
    3 Buy, 9 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 20 | Down: 26 | New: 20
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on FibroGen (NASDAQ: FGEN) to $2.00 (from $16.00) while maintaining a Sell rating.

You May Also Be Interested In

Related Categories

Analyst PT Change, Hot Comments